Emory University
201 Dowman Drive
Atlanta
Georgia
30322
United States
Tel: 404-727-6123
Website: http://www.emory.edu/
244 articles about Emory University
-
Chemical Insights Research Institute and Emory University's Rollins School of Public Health Team to Study the Human Health Impact of PFAS Chemical Exposure
2/21/2023
Chemical Insights Research Institute of UL Research Institutes and Emory University's Rollins School of Public Health have announced upcoming research to study human exposure to per- and polyfluoroalkyl substances.
-
Ravi I. Thadhani, MD, MPH, appointed Executive Vice President for Health Affairs at Emory University
10/27/2022
Following an extensive international search, Emory University announced that Ravi I. Thadhani, MD, MPH, has been appointed executive vice president for health affairs.
-
Emory University's Ken Thorpe told BioSpace that the average Medicaid spending on drugs approved under the accelerated pathway in relation to total Medicaid spending is.2%.
-
The arrangement provides the opportunity for LJI faculty and postdocs to make a more immediate impact on drug development while offering a different perspective to KKNA.
-
In November 2019, Emory realized this experimental drug could have significant potential in respiratory viruses such as COVID-19.
-
Replicate focuses on using self-replicating RNA (srRNA) to develop therapies for autoimmune and inflammatory diseases and prevent drug resistance in cancer.
-
The two companies said a booster dose given six months after the second dose had a consistent tolerability profile while still creating high immune responses against the Alpha and Beta variant.
-
Polyphor said there has been no improvement in the results for FORTRESS, its Phase III global study for the possible treatment of patients with breast cancer.
-
Emory University to Host a Live Webcast With His Holiness the Dalai Lama
11/30/2020
The Center for Contemplative Science and Compassion-Based Ethics at Emory University will host a live webinar with His Holiness the Dalai Lama on Tuesday, December 8, 2020. A discussion titled “The Necessity of Compassion for the Survival of Humanity” will feature the Dalai Lama in conversation with Melani A. Walt
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 1, 2020.
-
FDA Clears the Way for Ridgeback Biotherapeutics to begin Human Testing of a Promising Potential Treatment for COVID-19
4/7/2020
Ridgeback Biotherapeutics LP and Drug Innovations at Emory, LLC, announced that the U.S. Food and Drug Administration has approved an Investigational New Drug application by Drug Innovation Ventures at Emory, LLC, wholly owned by Emory University, for an orally available antiviral compound, EIDD-2801, exclusively licensed to Ridgeback Biotherapeutics, LP, a closely held biotechnology company.
-
Ridgeback Biotherapeutics and Drug Innovations Ventures at Emory Partner to Develop Clinical Stage Coronavirus Treatment
3/19/2020
Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory, LLC, a not-for-profit biotechnology company wholly owned by Emory University, announced a collaboration to rapidly advance DRIVE's EIDD-2801, a promising oral COVID-19 treatment, into human testing.
-
Gilead Sciences COMPASS Initiative™ Awards Over $2.3M to 40 Organizations Fighting HIV in the South
12/5/2019
New Funding is Third Year of National Initiative to Reduce HIV Infection Rate in Southern States
-
OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung Cancer - June 25, 2019
6/25/2019
OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on Non-Small Cell Lung Cancer Monday, July 1, from 5-9 p.m. at the Whitley in Atlanta.
-
Moleculin Announces Agreement with Emory University to Conduct Pediatric Brain Tumor Trial
4/11/2019
Moleculin Biotech, Inc. announced it has entered into an agreement with Emory University to conduct a Phase 1 clinical trial of WP1066 in children with recurrent or refractory malignant brain tumors.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Although bioterrorism doesn’t get the kind of attention more traditional bombings and shootings receive, the biotech industry and the federal government are paying attention and actively funding and developing countermeasures to potential bioterror, military and public health emergencies.
-
Celltrion Signs 'Incubation' Agreement with Emory University for Development of New Drugs for Atherosclerosis
9/20/2018
Research on new mechanisms to prevent ischemic heart disease and stroke, the leading causes of death in the world
-
The death of Sen. John McCain helped raise awareness about the plight of brain tumor patients and the lack of movement on developing new therapies for this disease over the past several years. But now, Houston-based Moleculin Biotech has launched a clinical trial that could be a game-changer if a...
-
Kaiser Permanente and Emory Healthcare Announce New Collaboration for Integrated Care
6/13/2018
Emory Healthcare and Kaiser Permanente will collaborate to develop a new care model that provides Kaiser Permanente members with a fully integrated health care experience, and in the process advances patient- and family-centered care in metro Atlanta and beyond.